Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +34.35%
#2 Siren Siren +31.73%
#3 OriginTrail OriginTrail +18.20%
#4 Purr Purr +17.28%
#5 龙虾 (Lobster) 龙虾 (Lobster) +12.28%
#6 Ethena Staked ENA Ethena Staked ENA +11.62%
#7 Wrapped XPL Wrapped XPL +11.23%
#8 DigiByte DigiByte +11.00%
#9 Collect on Fanable Collect on Fanable +10.98%
#10 Plasma Plasma +10.85%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Rang in Aktien #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Aktienkurs
$50.82
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$102.09M
Veränderung (1 Tag)
1.90%
Veränderung (1 Jahr)
-
Land
US
Handel Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Kategorie

Healthcare
Preis COAG mit Marktkapitalisierung von B
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
COAG
$50.82
Marktkapitalisierung von Hemab Therapeutics Holdings, Inc. Common Stock(COAG)
Marktkapitalisierung: $102.09M
Mit Stand August 2026 hat Hemab Therapeutics Holdings, Inc. Common Stock eine Marktkapitalisierung von $102.09M. Das macht Hemab Therapeutics Holdings, Inc. Common Stock laut unseren Daten zum 21709th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Hemab Therapeutics Holdings, Inc. Common Stock von 2026 bis 2026
COAG im Vergleich zu den Top 5 der beliebtesten stocks
Preis für COAG Vermögenswert B Marktkapitalisierung von B Ergebnisse
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,594,322 $102.09M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +5,104,822.70%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,263,459 $102.09M
Apple Inc. Apple Inc.
AAPL
$4.547T +4,453,775.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$2,072,162 $102.09M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +4,077,354.21%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,788,562 $102.09M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,519,305.23%
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock
$1,390,338 $102.09M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,735,708.14%